Autopsy report · NCT00287664

Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“because in a preliminary analysis we would need 1000 patients per group to achieve significative differences in the main end point.”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 years after it had already started.
Suspended: paused, and may or may not restart.
100 participants enrolled.

Vital statistics

Status: Suspended
Phase: Phase 4
Sponsor: Hospital Clinic of Barcelona
Sponsor type: University, hospital or other
Conditions: Cirrhosis; Hepatorenal Syndrome
Interventions: terlipressin
Participants: 100
Sites: 1
Countries: Spain

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.